Market Tracker

04/29 11:54am ET

Myriad Genetics Inc (NASDAQ:MYGN)

36.07
Delayed Data
As of 11:39am ET
 -1.08 / -2.91%
Today’s Change
30.30
Today|||52-Week Range
46.24
-16.43%
Year-to-Date

Today’s Trading

Previous close37.15
Today’s open36.89
Day’s range35.91 - 37.06
Volume142,942
Average volume (3 months)941,921
Market cap$2.6B
Dividend yield--
Data as of 11:39am ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+14.63%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-7.08%
P/E ratio27.1
Price/Sales3.50
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-2.20-3.24%
LGNDLigand Pharmaceutica...-3.12-2.53%
IPXLImpax Laboratories I...-1.32-3.86%
MDCOMedicines Co-0.50-1.40%
Data as of 11:54am ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.38
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts